Cargando…

Virtual reality exposure therapy for posttraumatic stress disorder (PTSD): a meta-analysis

Contrary to specific phobias, for which Virtual Reality Exposure Therapy (VRET) constitutes an effective treatment, uncertainty still exists regarding the usefulness of VRET for posttraumatic stress disorder (PTSD). Therefore, this meta-analysis investigated the efficacy of VRET for PTSD as compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Kothgassner, Oswald D., Goreis, Andreas, Kafka, Johanna X., Van Eickels, Rahel L., Plener, Paul L., Felnhofer, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713125/
https://www.ncbi.nlm.nih.gov/pubmed/31489138
http://dx.doi.org/10.1080/20008198.2019.1654782
_version_ 1783446822766772224
author Kothgassner, Oswald D.
Goreis, Andreas
Kafka, Johanna X.
Van Eickels, Rahel L.
Plener, Paul L.
Felnhofer, Anna
author_facet Kothgassner, Oswald D.
Goreis, Andreas
Kafka, Johanna X.
Van Eickels, Rahel L.
Plener, Paul L.
Felnhofer, Anna
author_sort Kothgassner, Oswald D.
collection PubMed
description Contrary to specific phobias, for which Virtual Reality Exposure Therapy (VRET) constitutes an effective treatment, uncertainty still exists regarding the usefulness of VRET for posttraumatic stress disorder (PTSD). Therefore, this meta-analysis investigated the efficacy of VRET for PTSD as compared to waitlist and active comparators. A literature search yielded nine controlled studies encompassing 296 participants (124 VRET, 172 controls). The differences between conditions regarding the primary outcome of PTSD symptom severity and the secondary outcome of depressive and anxiety symptoms post-treatment were calculated using Hedges’ g. Compared to waitlist controls, VRET showed a significantly better outcome for PTSD symptoms (g = 0.62, p = .017) and depressive symptoms (g = 0.50, p = .008). There was no significant difference between VRET and active comparators regarding PTSD symptoms (g = 0.25, p = .356) and depressive symptoms (g = 0.24, p = .340) post-treatment. No significant effects emerged for anxiety symptoms. These findings suggest that VRET may be as effective as active comparators for PTSD patients. However, the results must be interpreted with caution due to the limited number of trials and the substantial number of – predominantly male – military service members studied. Additional controlled trials, considering a wider range of trauma types and balanced gender, are required to strengthen the evidence.
format Online
Article
Text
id pubmed-6713125
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-67131252019-09-05 Virtual reality exposure therapy for posttraumatic stress disorder (PTSD): a meta-analysis Kothgassner, Oswald D. Goreis, Andreas Kafka, Johanna X. Van Eickels, Rahel L. Plener, Paul L. Felnhofer, Anna Eur J Psychotraumatol e-Health applications in the field of traumatic stress Contrary to specific phobias, for which Virtual Reality Exposure Therapy (VRET) constitutes an effective treatment, uncertainty still exists regarding the usefulness of VRET for posttraumatic stress disorder (PTSD). Therefore, this meta-analysis investigated the efficacy of VRET for PTSD as compared to waitlist and active comparators. A literature search yielded nine controlled studies encompassing 296 participants (124 VRET, 172 controls). The differences between conditions regarding the primary outcome of PTSD symptom severity and the secondary outcome of depressive and anxiety symptoms post-treatment were calculated using Hedges’ g. Compared to waitlist controls, VRET showed a significantly better outcome for PTSD symptoms (g = 0.62, p = .017) and depressive symptoms (g = 0.50, p = .008). There was no significant difference between VRET and active comparators regarding PTSD symptoms (g = 0.25, p = .356) and depressive symptoms (g = 0.24, p = .340) post-treatment. No significant effects emerged for anxiety symptoms. These findings suggest that VRET may be as effective as active comparators for PTSD patients. However, the results must be interpreted with caution due to the limited number of trials and the substantial number of – predominantly male – military service members studied. Additional controlled trials, considering a wider range of trauma types and balanced gender, are required to strengthen the evidence. Taylor & Francis 2019-08-19 /pmc/articles/PMC6713125/ /pubmed/31489138 http://dx.doi.org/10.1080/20008198.2019.1654782 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle e-Health applications in the field of traumatic stress
Kothgassner, Oswald D.
Goreis, Andreas
Kafka, Johanna X.
Van Eickels, Rahel L.
Plener, Paul L.
Felnhofer, Anna
Virtual reality exposure therapy for posttraumatic stress disorder (PTSD): a meta-analysis
title Virtual reality exposure therapy for posttraumatic stress disorder (PTSD): a meta-analysis
title_full Virtual reality exposure therapy for posttraumatic stress disorder (PTSD): a meta-analysis
title_fullStr Virtual reality exposure therapy for posttraumatic stress disorder (PTSD): a meta-analysis
title_full_unstemmed Virtual reality exposure therapy for posttraumatic stress disorder (PTSD): a meta-analysis
title_short Virtual reality exposure therapy for posttraumatic stress disorder (PTSD): a meta-analysis
title_sort virtual reality exposure therapy for posttraumatic stress disorder (ptsd): a meta-analysis
topic e-Health applications in the field of traumatic stress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713125/
https://www.ncbi.nlm.nih.gov/pubmed/31489138
http://dx.doi.org/10.1080/20008198.2019.1654782
work_keys_str_mv AT kothgassneroswaldd virtualrealityexposuretherapyforposttraumaticstressdisorderptsdametaanalysis
AT goreisandreas virtualrealityexposuretherapyforposttraumaticstressdisorderptsdametaanalysis
AT kafkajohannax virtualrealityexposuretherapyforposttraumaticstressdisorderptsdametaanalysis
AT vaneickelsrahell virtualrealityexposuretherapyforposttraumaticstressdisorderptsdametaanalysis
AT plenerpaull virtualrealityexposuretherapyforposttraumaticstressdisorderptsdametaanalysis
AT felnhoferanna virtualrealityexposuretherapyforposttraumaticstressdisorderptsdametaanalysis